In CCA patients, the expression of MUC4 in GEM-based chemotherapy-treated patients with partial response (PR) or stable disease (SD) was lower than its expression in GEM-based chemotherapy-treated patients with progressive disease (PD; Figure 6E-F). Here, MUC4 is linked to cholangiocarcinoma.